DLHL
GSK icon

Donald L. Hagan LLC’s GSK GSK Stock Holding History

Donald L. Hagan LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,255
Closed -$64K – 172
2016
Q1 		$64K Buy
+1,255
New +$62.5K 0.06% 124
2015
Q4 		– Sell
-1,095
Closed -$53K – 162
2015
Q3 		$53K Buy
+1,095
New +$57K 0.05% 137

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Donald L. Hagan LLC's GSK Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of GSK (GSK) in Q2 2016, closing a stake of 1,255 shares — an estimated $64K sold.

Donald L. Hagan LLC first reported a position in GSK in Q3 2015 and held it in 2 quarters. The position peaked at $64K in Q1 2016. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 1,255 GSK shares in Q2 2016, an estimated $64K.
  • Donald L. Hagan LLC first reported a position in GSK in Q3 2015 and held it in 2 quarters.
  • Donald L. Hagan LLC's GSK position peaked at $64K in Q1 2016.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.